Ireland
Ireland will help you pay for Europe. It will not help you pay for India.
This is the first thing an Irish patient should know, and it is the thing you are least likely to be told by anyone selling treatment abroad.
The HSE says the Cross Border Directive is a scheme to get planned healthcare in another EU or EEA country, that it can no longer be used to access healthcare in the UK because the UK left the EU, and that a separate scheme applies to private treatment in Northern Ireland. India is not in the EU or the EEA, so treatment in India is not reimbursable under the scheme
Health Service Executive, Cross Border Directive: get healthcare abroad Checked 2026-09-26.
Read directly from the live HSE page on 26 September 2026; the page shows no date of its own and the rules change. A statement of the scheme scope, not advice about an individual entitlement. The HSE also runs a separate Treatment Abroad Scheme, which this page does not cover. Anyone relying on this should confirm their own position with the HSE before booking anything.
So for most procedures, the Cross Border Directive is simply the better route and you should use it. You are treated in Europe, you claim a large part of the cost back, and you are two hours from home instead of nine.
We are telling you that on our own page, about our own service, because it is true for more Irish patients than the alternative is.
Medically reviewed
Reviewed by Dr Gunjan Patel, MBBS, registered with the Gujarat Medical Council (G-65059). Reviewed for accuracy only. This page is general information, not advice about your own case, and Dr Gunjan Patel does not diagnose, prescribe or treat.
Start here, not with us
How the Cross Border Directive works in practice.
Written out in full because it is the option most people reading this page should take.
If you are eligible for the treatment in the Irish public system, you can have it in another EU or EEA country, pay the provider yourself, and then apply to the HSE for payment towards the cost afterwards.
The HSE says that to use the Cross Border Directive you must be eligible for the same healthcare in the Irish public system and have an outpatient consultation before inpatient or day case treatment, that prior notification before you travel for inpatient or day case treatment is optional, and that it lets the HSE confirm whether you are eligible to apply for healthcare costs and give an indication of how much you might get, with the exact amount confirmed only after treatment
Health Service Executive, Cross Border Directive: get healthcare abroad and prior notification Checked 2026-09-26.
Read directly from the live HSE pages on 26 September 2026; the pages show no date of their own and the rules change. The eligibility and outpatient consultation rules are from the HSE page Get healthcare abroad with the Cross Border Directive Scheme (/cross-border-directive/how-to-get/), re-read on 3 October 2026. You still apply for the healthcare costs after treatment. Whether you qualify, and for what, is decided by the HSE for your case, so confirm with the HSE Cross Border Directive team before you travel. Not advice about an individual entitlement.
The HSE says that under the Cross Border Directive you pay the provider yourself and can then claim the smaller of the cost of your healthcare abroad and the cost of the same healthcare in the Irish public system, that you are responsible for any shortfall, and that travel, accommodation and translation costs are not covered
Health Service Executive, Cross Border Directive: how much you can claim Checked 2026-09-26.
Read directly from the live HSE pages on 26 September 2026; the pages show no date of their own, and the HSE reviews its published prices each year. The shortfall wording is from the HSE prior notification page, and the line on travel, accommodation and translation costs is from the HSE page Get healthcare abroad with the Cross Border Directive Scheme (/cross-border-directive/how-to-get/). What the HSE would pay for your procedure is set by the HSE, so ask it for an indication before you commit. Not advice about an individual entitlement.
The HSE publishes the current rules, and they change. Read them yourself before you commit to anything, including anything we suggest.
Use the Directive, not us, when
- Your procedure is routine and widely performed across Europe
- You are eligible for the same treatment in the public system and can apply
- The reimbursement covers enough of the cost to matter
- A shorter flight and a nearer recovery are worth something to you
That covers a large share of the people who will read this page, and we would rather say so plainly than bury it below a sales argument.
The scale of the wait
Why the question comes up at all.
HSE waiting lists, published by the National Treatment Purchase Fund.
114,921
patients were waiting for an inpatient or day case treatment appointment in Irish public hospitals at the end of August 2026, and 687,839 for a first hospital outpatient consultation, according to the National Treatment Purchase Fund
National Treatment Purchase Fund, "NTPF publishes August 2026 national public hospital waiting list data" Checked 2026-10-03.
Read on 3 October 2026; published 11 September 2026. These are separate lists, not one inside the other. A third list in the same release, 42,726 patients waiting for a GI endoscopy appointment, is counted separately again and is in neither figure. The NTPF also publishes a Planned Procedure list, which counts patients who have already had treatment and need further treatment at a future date, such as surveillance scopes, so it is not a measure of people waiting for a first operation.
Those are two separate lists, not one inside the other: one counts people waiting for a first hospital outpatient consultation, the other people waiting for an appointment for inpatient or day case treatment.
Numbers at that scale, on HSE waiting lists, are why the question of treatment abroad is asked so often here, and why so many companies are willing to answer it enthusiastically. Whether the wait itself harms you is a separate question, and what the evidence says about waiting for surgery covers it.
What the numbers do not settle
A long list is a reason to look at your options. It is not, by itself, a reason to fly nine hours. Those are two different decisions and they get run together constantly.
The first question is whether the Directive can help you. Only if the answer is no does the rest of this page apply.
Weight loss surgery specifically
What the HSE itself has said about bariatric surgery capacity.
The general waiting list figures above cover Irish hospital care as a whole. This specialty has its own numbers, and some of them are the starkest on this site.
Roughly six-fold was the rise in bariatric surgery capacity the HSE told reporters, in October 2019, that Ireland needed, to around 1,000 procedures a year, at an estimated extra cost of about 7 million euro. 168 publicly funded bariatric procedures were carried out in Ireland in 2018, a 56 percent rise on the year before, while about 370 patients were on the waiting list at the time.
Irish Examiner, 23 October 2019, citing an HSE statement Checked 2026-09-08.
A capacity estimate the HSE gave to one newspaper in 2019, not a costed plan document we could fetch directly. We use it because it is the HSE’s own account of the size of the problem, in its own words, not because we independently audited the underlying planning.
Irish Examiner, 23 October 2019, citing HSE figures Checked 2026-09-08.
HSE figures as relayed to a single newspaper in 2019. We have not found a primary HSE statistical release carrying the same figures independently, which is also why the more recent 2023 figures below need their own caveat.
we have the fewest numbers of bariatric surgeries in the Western world
Health Service Executive, quoted by the Irish Examiner, 23 October 2019 Checked 2026-09-08.
A quoted HSE statement to one newspaper, not an audited international ranking. It is the HSE’s own description of its service, not a claim we checked against every other Western country’s published figures.
12 per million
was Ireland’s own bariatric surgery rate in 2018, which is why the Royal College of Physicians of Ireland asked for it to rise to 200 per million within two to three years, an interim target that still sat below the roughly 400 to 600 per million other countries were already carrying out, not at the lower end of that range
Irish Heart Foundation, reporting the Royal College of Physicians of Ireland Obesity Clinical Advisory Group, 20 August 2019 Checked 2026-09-08.
From a patient advocacy charity’s coverage of the professional body’s own figures, not a Royal College press release we could fetch directly. The 200 per million figure was the College’s own requested interim target, not a claim that it matched normal practice elsewhere. It sat below the entire 400 to 600 per million range cited for other countries, not at the lower end of it.
9 deaths
on the bariatric surgery waiting list were recorded over roughly the five years before a 2018 study presented at a national surgical symposium, alongside a 51 percent rate of patients developing a new obesity-related illness while waiting, 13 percent developing new cardiac disease, and an average wait of 3.3 years, up to six for some. This describes the position as it stood then, not the current wait
Irish Heart Foundation, 7 September 2018 Checked 2026-09-08.
Findings as presented at a surgical symposium and reported by a patient advocacy charity, not a peer reviewed paper we have located and read directly ourselves. The period covered runs to roughly 2018, so this describes conditions from about 2013 to 2018 and must not be read as a description of today’s wait.
More recent figures do not resolve cleanly, and we would rather say so than pick one. 219 bariatric procedures had been carried out in Ireland’s public system in 2023 as of 14 December that year, an HSE spokesperson told one newspaper, already ahead of a revised internal target of 200; a separate 2026 Freedom of Information release puts the 2023 total, on a broader definition including gastric balloon insertions, meaningfully higher, at 320. 320 and 208 bariatric procedures, a category reported as including gastric balloon insertions alongside surgery, were recorded in Ireland’s public system for 2023 and 2024 respectively in a 2026 Freedom of Information release, a 35 percent fall year on year. That gap is not a rounding error. It is a fair demonstration of how hard it is to get one clean number out of this system, which matters more than the number itself when you are the one trying to plan around it.
Medical Independent, 21 January 2024, citing an HSE spokesperson Checked 2026-09-08.
A near-year figure given to one newspaper by an HSE spokesperson rather than published in a standalone HSE statistical release. A separate figure for the same year, reported later from a Freedom of Information release, puts the 2023 total meaningfully higher. See the paired entry below before treating either number as definitive.
Echo Live, 2 January 2026, citing a Freedom of Information release from the HSE Checked 2026-09-08.
This figure appears to count a broader category, procedures plus gastric balloon insertions, than the 219 figure reported for 2023 by a different newspaper the year before, which may explain most or all of the gap, though we have not confirmed this directly against the underlying Freedom of Information release. We have not found a primary HSE statistics release that states which figure, or which definition, is official. Treat both 2023 figures as real and both as unreconciled.
A well documented wait is a reason to look at your options
It does not, by itself, decide which one is right. Bariatric surgery is the specialty on this site where our usual model fits least well, and a thoroughly evidenced Irish waiting list does not change that. The operation is the short part. The NHS says follow-up appointments continue for the rest of your life, with the supplements and blood tests falling to whoever looks after you afterwards, and that has to be arranged before anyone books a flight, not after landing back home.
So this waiting list is a real reason to price every option side by side: the Cross Border Directive into Europe, private treatment at home, and India among them. It is not a reason to skip the aftercare question, which belongs in that comparison regardless of which country you choose.
IVF with a donor egg or donor sperm
Donor eggs or donor sperm: where the usual logic on this page runs out.
This is narrow by design, for the minority of readers here for whom a donor gamete is not optional.
The HSE says this plainly, not in fine print. The HSE states plainly that you are not currently eligible for free IUI, IVF or ICSI through the HSE if you cannot use your own eggs or sperm, if you are in a same-sex couple, or if you are single, and that it will update this once suitable regulation for donor treatment is in place. If any part of your route to a child runs through a donor egg or donor sperm, this is not a gap in eligibility. It is the stated rule, today.
Health Service Executive, ‘Getting IVF and other specialist treatment through the HSE’ Checked 2026-09-08.
Ireland’s public AHR scheme has been funding a first cycle of IVF or ICSI since September 2023 through this same access-criteria framework, so this exclusion is a live, currently applied rule rather than a historical footnote. Confirm your own position directly with the HSE before relying on it.
The HSE’s own page on what the Cross Border Directive covers lists IVF, IUI and ICSI as available under the scheme, but states you must meet the access criteria for that treatment as it applies in Ireland, and have treatment that is also publicly available in Ireland. No HSE page spells out in one place what that means for a donor-gamete cycle, so this is our reading of two pages together rather than a sentence the HSE has written for you: on the plain wording of the scheme, failing the domestic criteria at home gives you no stronger claim to reimbursement for the same treatment in Spain or the Czech Republic, two of the destinations Irish patients travel to for donor eggs. Confirm this directly with the HSE Cross Border Directive team before ruling it out on our word alone. Spain’s own government registry does not break Ireland out as a separate line, though it does record a rising count of UK-resident cycles each year, all treatment types together rather than donor eggs alone. 34,849 foreign-resident IVF cycles (2023) were recorded by Spain’s national assisted reproduction registry, up from 27,564 in 2022 and 22,010 in 2021, with the United Kingdom the third largest source country in each of the three years and egg donation accounting for more than half of the foreign-resident total every year: UK-resident cycles rose from 1,397 (6.3 percent) in 2021 to 2,471 (9.0 percent) in 2022 to 2,818 (8.1 percent) in 2023. The Czech Republic’s national registry does list women with Irish citizenship as a separate line for donor-egg cycles, though it counts citizenship rather than country of residence. 192 donor-egg recipient cycles were recorded for women with Irish citizenship in the Czech Republic in 2023, after 173 in 2021 and 249 in 2022, in the Czech national assisted reproduction registry, which lists Ireland among the ten most frequent citizenships for donor-egg cycles in 2023. A fuller comparison of Spain and India for fertility treatment sets out what is and is not documented for an Irish reader specifically.
Health Service Executive, ‘Cross Border Directive - Types of healthcare available’ Checked 2026-09-08.
The page does not itself spell out how the domestic donor-gamete, same-sex-couple or single-applicant exclusion interacts with this condition. Treating the two HSE pages together, so that failing the domestic access criteria also fails the Directive’s condition, is this site’s own reading, not a sentence the HSE has published in one place. Confirm your own case directly with the HSE Cross Border Directive team.
Read directly from the three primary registry reports rather than a secondary summary. Ireland is not broken out as its own line in any of the three years and is folded into a residual "Otros" (other) category covering 17.7 to 22.2 percent of the total, so no Ireland-specific cycle count exists in this registry at all, a real gap against the UK figures above rather than an equivalent one.
Czech Institute of Health Information and Statistics (ÚZIS), National Registry of Reproductive Health, data summary NR-09-03, table 6 (processed 31 October 2025) Checked 2026-10-03.
Read on 3 October 2026 from the registry’s own data file. It counts cycles, not women or births, and is published with a lag, so 2023 is the latest year. Women with UK citizenship recorded 242 cycles in 2023. The registry records citizenship, not country of residence, so these counts are not directly comparable with Spain’s residence-based figures, and it names a country only when it is among the ten most frequent citizenships in the latest year: Ireland was ninth of the ten for donor-egg cycles in 2023, a list that includes Czech citizens. Czech law (Act 373/2011, section 11) gives a donor no entitlement to payment, only to documented expenses.
This is also, disproportionately, a question for single people and same-sex couples, and Indian law has an answer that has nothing to do with donor banks. India’s ART Act defines a commissioning couple as an infertile married couple, and separately defines ‘woman’ as any woman above twenty-one years of age who approaches a clinic or bank, with no marital-status qualifier written into that second definition, though whether this wording alone guarantees eligibility for a single foreign woman in practice is unconfirmed and should be verified in writing with a registered clinic before travelling. India’s Supreme Court declined to legally recognise same-sex marriage in its 17 October 2023 ruling in Supriyo v Union of India, holding that recognising it is a matter for Parliament rather than the courts, so a same-sex couple cannot currently marry under Indian law. A single woman above twenty-one can approach a clinic in her own right under a separate part of the same Act, though how a specific bank applies that to a foreign single woman is worth confirming in writing rather than assuming. A single man has no category in the Act at all.
Assisted Reproductive Technology (Regulation) Act, 2021 (Act No. 42 of 2021), section 2(e) and section 2(u) Checked 2026-09-08.
This is the Act’s own wording. Secondary legal commentary describes administrative practice as narrower for single women in places, a rule that unambiguously applies to surrogacy under the separate Surrogacy Act rather than to ordinary ART. We could not confirm from a primary ART Rules text whether a narrower reading also governs plain donor-gamete IVF for a foreign single woman. Treat that specific point as unresolved and confirm it in writing with a registered clinic and independent Indian legal advice.
Supreme Court of India, Supriyo v Union of India, reported via corroborating legal reporting Checked 2026-09-08.
Read via secondary legal reporting rather than the judgment text itself, though the date and outcome are corroborated across multiple independent sources. That a same-sex couple therefore cannot qualify as a commissioning couple under the ART Act, which requires a married couple, is this site’s own reading of the two facts together, not a sentence either the court or the Act states directly.
Where a donor egg or donor sperm is the only route, and you have confirmed you would be recognised as an intending parent under Indian law, the mechanics are narrower than surrogacy and separate from it. India’s Assisted Reproductive Technology (Regulation) Act 2021 requires donor gametes for IVF or ICSI to be sourced only from a bank registered as an independent entity, bars that bank from supplying one donor’s sperm or oocyte to more than one commissioning couple, and requires the commissioning couple or woman to insure the oocyte donor for twelve months. Surrogacy is a different law, closed to foreign nationals apart from a narrow route for couples of Indian origin, and the two should never be confused, on this page or anywhere else.
Assisted Reproductive Technology (Regulation) Act, 2021 (Act No. 42 of 2021), sections 21(b), 22(1)(b), 27(1), 27(3) and 27(4) Checked 2026-09-08.
Read from the Act as gazetted 18 December 2021. The detailed procedural mechanics sit in the subordinate ART Rules 2022, which we were not able to render as extractable text from the government’s own PDF, so treat these Act-level provisions as settled and confirm any Rules-level procedural detail directly with a registered ART bank.
If a donor gamete is your situation
If that is not your situation, the rest of this page’s logic holds without qualification: use the Directive where you can, and treat India as the exception. If it is your situation, two separate questions have to clear before cost becomes the question at all.
First, the marital-status rule under India’s ART Act, which excludes a same-sex couple entirely as things stand and leaves a single man with no category at all. Second, whether the HSE and the Cross Border Directive truly have nothing for you, which is worth confirming directly with the HSE rather than taking this page’s word for it. We will not tell you India is the answer because Ireland said no twice. Sometimes, after both checks, the honest answer is that no country currently has a lawful route that fits your situation, and you deserve to hear that plainly rather than be sold a flight.
The narrow case
When India is worth pricing anyway.
A short list, because the list of good reasons is short.
India may be worth considering when
- Your procedure is complex or a revision, such as a revision joint replacement, and the European centres offering it are few and heavily booked
- The expertise you need is concentrated somewhere with high volume in that specific operation
- Even with no reimbursement, the total is lower than the part of a European bill you would still be carrying
- You want an independent opinion first, and treatment is not yet the decision on the table
Stay with Europe when
- Your procedure is routine
- You are eligible to apply and the reimbursement is meaningful
- Flying long haul is unwise for you medically
- You would be travelling without anyone to help you afterwards
Recovering closer to home, inside a system that will reimburse you, is worth more than a headline price difference.
Ireland specific
Five things to settle before anything else.
Most of what makes an Irish decision different is administrative rather than clinical, and it is all decidable before you spend money.
For the second item, what the Directive would reimburse, you can get an estimate before you go, but the HSE confirms the exact amount only after treatment. The HSE says that for inpatient or day case treatment, the Irish public cost it uses for a Cross Border Directive claim comes from one diagnosis-related group (DRG) code assigned to the case, that it reviews and updates DRG prices every year and they can go up or down, and that it sometimes sends applications to the Healthcare Pricing Office to check the code.
Health Service Executive, Cross Border Directive: how much you can claim Checked 2026-10-03.
Read on 3 October 2026. The HSE publishes a guide to common DRG codes and full price lists on the same page; we point to them rather than copy euro figures, because the prices change. Outpatient claims do not use DRG codes; the HSE sets a fixed maximum for outpatient appointments instead. Not advice about an individual entitlement.
- Whether you are eligible under the Cross Border Directive at all, confirmed with the HSE rather than assumed
- What the Directive would reimburse for your specific procedure, so the comparison is a real number and not a guess
- Whether your GP will take back your follow up, agreed in advance and in writing
- Your insurance position, since the Department of Foreign Affairs says appropriate travel insurance is essential for treatment abroad
- A medical visa for India, and how long yours takes to obtain
Every cost line, including the ones that go wrong
What official bodies say about insurance for treatment abroad
Questions
What Irish patients ask us.
Can I claim anything back for treatment in India?
No. The Cross Border Directive covers the EU and the EEA, and India is in neither. The HSE’s separate Treatment Abroad Scheme reaches the UK and Switzerland as well, but not India. Any company suggesting otherwise is either mistaken or telling you what you want to hear, and either one is a reason to stop and check with the HSE directly.
Is it true that nine people died waiting for bariatric surgery in Ireland?
That figure comes from a study presented at a national surgical symposium in 2018, looking back across roughly the five years before it. It describes roughly 2013 to 2018, not the present day, and we have not found a more recent study repeating the same count. The figure is real. It is also old enough that it should not be read as a description of today’s wait without saying so.
Which 2023 figure is right for Ireland's public bariatric surgeries, 219 or 320?
We do not know, and we would rather say that plainly than guess. One HSE-attributed figure, given to a newspaper in January 2024, says 219 for 2023. A different HSE-attributed figure, from a Freedom of Information release reported in January 2026, says 320 for the same year. We have not found a published HSE statistics release that settles which one is correct. Both are real numbers from real, checkable sources. Neither is final, and we will update this page if that changes.
Does a wait this long mean I should choose India over waiting in Ireland?
Not automatically, and not on its own. A documented wait is a reason to compare every option against each other with real numbers, not a verdict already reached. The harder question this specialty always asks, who runs your blood tests and sees you for follow-up in year three, wherever you have the operation, matters more than which country’s waiting list looks worse on paper.
Can I use the Cross Border Directive for donor-egg IVF in Spain or the Czech Republic?
Probably not, though the HSE has not written a single sentence that settles it. The Directive lists IVF, IUI and ICSI as covered treatment, but reimbursement requires meeting the same access criteria that apply in Ireland, and the HSE’s own domestic criteria rule out anyone who cannot use their own eggs or sperm. Confirm your own case with the HSE Cross Border Directive team directly. It is a short call that is worth more than anything on this page.
I'm single, or in a same-sex relationship. Does India change anything?
It changes the question, not automatically the answer. India’s ART Act lets a single woman above twenty-one approach a clinic in her own right, but defines a commissioning couple as an infertile married couple, and India does not currently recognise same-sex marriage, so a same-sex couple cannot qualify as a commissioning couple and a single man has no category in the Act at all. None of that is about donor banks or clinic paperwork. It is about who Indian law currently treats as a parent in waiting, and it needs answering in writing before anything else on this page does.
How does India regulate donor eggs and donor sperm for ordinary IVF, as opposed to surrogacy?
Separately, and more permissively, than surrogacy. Donor gametes for IVF or ICSI must come from a bank registered under the ART Act, which cannot supply one donor to more than one couple, and the recipient couple must insure the egg donor for twelve months. Surrogacy runs under a different law entirely, which is why this site treats the two as separate questions rather than one. It is closed to foreign nationals apart from a narrow route for couples of Indian origin, who need a certificate of recommendation from the national Board.
Should I just use the Cross Border Directive instead?
For a routine procedure, very probably yes, and we would rather you did. It is a shorter flight, a nearer recovery and a substantial part of the cost returned. Come back to us if your case is complex enough that Europe cannot serve it quickly, or if what you need is an independent opinion rather than an operation.
Will the HSE treat me if something goes wrong afterwards?
You remain entitled to public healthcare in Ireland, and a complication is treated like any other clinical need. What makes that easier in practice is arriving home with a discharge summary, imaging and an operation note your own doctor can act on immediately. We put that handover in place before you fly rather than after you land.
Is private treatment in Ireland an option?
Yes, and for some procedures it is the fastest route of all. Price it alongside the Directive and alongside India before deciding anything. Three real quotes make the decision obvious far more often than argument does.
What if I only want an opinion, not treatment?
That is a complete service on its own, and it is unaffected by any of the reimbursement rules above, because no treatment is involved. You get an independent written opinion to take to your own consultant. What that includes.
Find out which of the three routes fits your case.
Thirty minutes, free, and no medical records needed to start. If the Cross Border Directive is the right answer for you, that is what you will hear.